Every statistic about public trust in science reveals less a knowledge gap than an abyss of distrust, a chasm that reason alone cannot bridge. Despite decades of data, surveys, and outreach campaigns, roughly three-quarters of Americans—76% in the latest Pew Research Center poll—report having at least some confidence in scientists to act in the public’s best interest; yet, more than one in four express little to no trust at all.

The Largest Deal Since ExxonMobil’s Merger in 1998 BP Struggles in the Aftermath of the Gulf of Mexico Oil Spill BP’s Push for Renewable Energy Development Also Becomes a Burden The UK-based global energy company Shell is repo

A plastic bag in a beachgoer’s tote is ecologically harmless; it only becomes a problem when carelessly discarded. This behavior is encouraged because society has not assigned a cost to it. Shoreline pollution is more about the mismanagement of behavior than the materials themselves—litter increases when the public faces no immediate consequences for throwing away plastic. However, if a visible fee were attached to the bag that accounted for cleanup costs, users would be more responsible, and beaches would remain clean without constant oversight.

China’s Imports of U.S. Agricultural Products Plunge 43% Last Month “Nightmare of the First Trade War Returns” — U.S.

Global biotech licensing deals: from 0% to 30% China surpasses the U.S. in number of oncology clinical trials U.S.

“The chronic problem of ‘sasaeng fans’ persists, causing turmoil in the industry.” “Fake fans disguised as ‘sasaengs’ are also emerging.” “Creating content for financial gain.”

Acquisition of SiteOne, Developer of Non-Opioid Painkillers Secures ‘STC-004,’ a Nav1.8 Inhibitor Entering Phase 2 Trials “Aims to Improve Treatment Accessibility and Reduce Dependency”

Contract Manufacturing Division Restructured as Independent Operation CDMO Market Growing at Double-Digit Rates Annually Industry Focus Shifting from ‘R&D → Production and Supply’

This article is based on ideas originally published by VoxEU – Centre for Economic Policy Research (CEPR) and has been independently rewritten and extended by The Economy editorial team. While inspired by the original analysis, the content presented here reflects a broader interpretation and additional commentary. The views expressed do not necessarily represent those of VoxEU or CEPR.

President Trump renews push for drug price cuts U.S.

Trump administration’s new executive order imposes strict limits on high-risk biological research Scientists warn the policy could severely hinder innovation and international collaboration America’s future role in global scientific leadership in jeopardy

Childhood vaccination rates in the U.S. are falling Recent outbreaks across North America have exposed the dangers of under-vaccinated communities Misinformation and political polarization—exacerbated by figures like Robert F.

A Severe Decline for Spirits Brands A Wider Trend: Distilleries Across the U.S.

The Bird Flu Outbreak and the Collapse of U.S.

The Controversial Decision: A Step Backward for HIV Prevention Evangelical Groups and Political Pressures The Public Health Backlash: Concerns About the Future of HIV Prevention

The Growing Measles Outbreak in Texas Why Measles Poses a Severe Risk to Pregnant Women and Babies Vaccination and Prevention: How to Protect Yourself and Your Community

The Rise of Open-Source AI: How Gemma 3 Fits Into the Trend Gemma 3 vs.

The Reality of Long COVID: Patient Narratives and Obstacles Unraveling the Science Behind Long COVID Managing Awareness, Rehabilitation, and Treatment Initiatives A Long C

The Rise of Vaccine Hesitancy: How Misinformation is Fueling a Measles Resurgence The NIH Takes Action: Fighting Misinformation to Protect Public Health A Call to Action: Stopping the Spread of Anti-Vaccine Propaganda

Struggles and Decline: Why Walgreens Chose to Sell Private Equity Takeover: A Risky Bet for Walgreens’ Future What’s Next?